Get the Stockscreener App
0.518
1.07%
0.0055
Pre-market:
.52
0.002
+0.39%
Curanex Pharmaceuticals Inc stock is traded at $0.518, with a volume of 547.13K.
It is up +1.07% in the last 24 hours and up +64.18% over the past month.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
See More
Previous Close:
$0.5125
Open:
$0.55
24h Volume:
547.13K
Relative Volume:
0.14
Market Cap:
$14.68M
Revenue:
-
Net Income/Loss:
$-1.29M
P/E Ratio:
-11.31
EPS:
-0.0458
Net Cash Flow:
$-9.72M
1W Performance:
+15.11%
1M Performance:
+64.18%
6M Performance:
-23.71%
1Y Performance:
+0.00%
1-Day Range:
$0.49
$0.555
1-Week Range:
$0.40
$0.5587
52-Week Range:
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Name
Curanex Pharmaceuticals Inc
Sector
Industry
Phone
718-673-6078
Address
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.518 | 14.52M | 0 | -1.29M | -9.72M | -0.0458 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Curanex Pharmaceuticals Inc Stock (CURX) Latest News
Top Curanex Pharmaceuticals (CURX) Competitors 2026 - MarketBeat
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours - MSN
Nasdaq tumbles over 350 points; US initial jobless claims increase - MSN
Curanex Pharmaceuticals IncTargets Ind Submission For Phyto-N In Q4 2026 - TradingView
Botanical drug used in China for 30 years clears key U.S. safety test - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria
CURANEX PHARMACEUTICALS INC (CURX) Fundamental Analysis & Valuation - ChartMill
Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India
Curanex adds two advisors to scientific board ahead of IND filing - Investing.com Australia
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - Bitget
TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board - Investing.com India
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - marketscreener.com
Veteran drug creators with HIV, HCV medicines join Curanex - Stock Titan
Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks
Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Curanex Forms World Class Scientific Advisory Board - Bitget
Botanical drug firm Curanex taps Fortune 100 pharma exec to guide R&D - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
Curanex Provides Operational Update on Key Regulatory Milestones - GlobeNewswire
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Curanex Pharmaceuticals Inc Stock (CURX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):